Skip to Main Content

Author Details

Dennis W Raisch
The University of New Mexico
1977
145
43
PMIDPaper TitleJournal TitlePublished Year
36317592Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment.Per Med2022
32540043A case-based learning exercise to increase students' understanding of the pharmacist's role in public health interventions for individual patients.Curr Pharm Teach Learn2020
29741230Randomized Controlled Trial to Evaluate an Internet-Based Self-Management Program in Systemic Sclerosis.Arthritis Care Res (Hoboken)2019
30773583Relationships Between Social/Emotional Support and Quality of Life, Depression and Disability in Patients With Chronic Obstructive Pulmonary Disease: An Analysis Based on Propensity Score Matching.Ann Behav Med2019
31173698Comparison of post-marketing surveillance approaches regarding infections related to tumor necrosis factor inhibitors (TNFi's) used in treatment of autoimmune diseases.Expert Opin Drug Saf2019
30590472The impact of a theory-based web-intervention on the intention to use prescription drugs for non-medical purposes among college students: a randomized controlled trial.Health Educ Res2019
27649938Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.Br J Haematol2018
28533080Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists.Res Social Adm Pharm2018
28635522Dietary Intake Among Opioid- and Alcohol-Using Pregnant Women.Subst Use Misuse2018
28063021Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project.Drugs R D2017
28635055Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).Cancer Med2017
26955658Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network.J Community Support Oncol2016
27819247Generic oncology drugs: are they all safe?Lancet Oncol2016
27268272Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system.Expert Opin Drug Saf2016
27489087Assessing the Quality of Economic Evaluations of FDA Novel Drug Approvals: A Systematic Review.Ann Pharmacother2016
25527101Improving the effectiveness of pharmacist-assisted tobacco cessation: a study of participant- and pharmacy-specific differences in quit rates.Ann Pharmacother2015
26393387Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.Expert Opin Drug Saf2015
27747765Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods.Drugs Real World Outcomes2015
25473731Assessing disparities in the receipt of inhaled corticosteroid prescriptions for asthma by Hispanic and non-Hispanic white patients.Ann Am Thorac Soc2015
24057195Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.Pediatr Radiol2014
27201597A Systematic Review To Identify the Use of Preference Elicitation Methods in Health Care Decision Making.Value Health2014
25456378Regulatory and clinical considerations for biosimilar oncology drugs.Lancet Oncol2014
25230161Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.Br J Radiol2014
25061552Predictors for mortality in hospitalized patients with chronic obstructive pulmonary disease.Springerplus2014
24771533Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.Cancer2014
24786458Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.Blood2014
24856596Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico.J Manag Care Spec Pharm2014
24328939Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project.Br J Dermatol2014
24108082Life-threatening dermatologic adverse events in oncology.Anticancer Drugs2014
24053773Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature.Expert Opin Drug Saf2014
21813583Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments.Clin Trials2013
24183258Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes.Diabetes Res Clin Pract2013
23814519Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.J Oncol Pract2013
23689765The effect of oxandrolone on the healing of chronic pressure ulcers in persons with spinal cord injury: a randomized trial.Ann Intern Med2013
23763530A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening.Expert Rev Pharmacoecon Outcomes Res2013
23421919The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.Alcohol Clin Exp Res2013
23463742Use of number needed to treat in cost-effectiveness analyses.Ann Pharmacother2013
23426763Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.J Bone Joint Surg Am2013
23399779Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis.Prostate Cancer Prostatic Dis2013
23480866Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.Expert Opin Drug Saf2013
23553448Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project.Drug Saf2013
22727534Determinants of nonmedical use, abuse or dependence on prescription drugs, and use of substance abuse treatment.Res Social Adm Pharm2013
22835704Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review.Res Social Adm Pharm2013
21987030Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.Qual Life Res2012
23244814Comparisons of Food and Drug Administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: report of the International Society for Pharmacoeconomics and outcomes research risk benefit management working group.Value Health2012
23111862Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).Semin Thromb Hemost2012
23111861A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR).Semin Thromb Hemost2012
23077434Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.J Oncol Pract2012
22515638Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.Cardiovasc Diabetol2012
22619083Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy.Diabetes Care2012
  • 1 - 50 of 145

Recommended Authors

HealthPartners Institute
Career Start Year 2011
Number of shared co-authors 0
Stanford University
Career Start Year 2010
Number of shared co-authors 1
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
St. Jude Children's Research Hospital Memphis
Career Start Year 2003
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 0
NYU Langone Hospital - Brooklyn Brooklyn
Career Start Year 2001
Number of shared co-authors 0
Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center
Career Start Year 2001
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 0
University of Washington
Career Start Year 1997
Number of shared co-authors 0
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 0
Medical University of South Carolina
Career Start Year 1996
Number of shared co-authors 1
Institute of General Practice and Family Medicine, University Hospital
Career Start Year 1996
Number of shared co-authors 0
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 0
University Health Network
Career Start Year 1994
Number of shared co-authors 0
Center for Healthcare Innovation, VA Greater Los Angeles Healthcare System
Career Start Year 1994
Number of shared co-authors 1
Virginia Commonwealth University
Career Start Year 1993
Number of shared co-authors 0
University of Southern California
Career Start Year 1992
Number of shared co-authors 1
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year 1990
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 0
Center for Drug Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 0
university of massachusetts amherst Chan Medical School
Career Start Year 1988
Number of shared co-authors 2
Epstein Health LLC
Career Start Year 1988
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 1
University of Iowa, School of Public Health
Career Start Year 1982
Number of shared co-authors 0
6 Department of Medical Informatics and Clinical Epidemiology.
Career Start Year 1981
Number of shared co-authors 0
School of Pharmacy, University of Washington
Career Start Year 1980
Number of shared co-authors 0
University of Toronto
Career Start Year 1977
Number of shared co-authors 0
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 2

Collaborators

University of South Carolina
Co-authored papers 41
Feinberg School of Medicine, Northwestern University
Co-authored papers 31
Feinberg School of Medicine, Northwestern University
Co-authored papers 20
Northwestern University Feinberg School of MedicineChicago
Co-authored papers 15
Northwestern Memorial Hospital
Co-authored papers 14
University of South Carolina College of Pharmacy
Co-authored papers 14
Central Texas Veterans Healthcare System
Co-authored papers 14
Tulane University School of Medicine
Co-authored papers 13
Feinberg School of Medicine, Northwestern University
Co-authored papers 11
Memorial Sloan-Kettering Cancer Center
Co-authored papers 10
548377Rush University Medical Center
Co-authored papers 9
Rutgers Robert Wood Johnson Medical School
Co-authored papers 9
Co-authored papers 8
Co-authored papers 5
University of Utah
Co-authored papers 5
University of California Los Angeles
Co-authored papers 3
University of Wisconsin School of Medicine and Public Health
Co-authored papers 3
University of Texas Southwestern Medical Center
Co-authored papers 3
Medical University of South Carolina
Co-authored papers 3
Duke University Medical Center
Co-authored papers 3
Northwestern University, Feinberg School of Medicine
Co-authored papers 3
McMaster University.
Co-authored papers 2
Department of Medical Informatics and Clinical Epidemiology
Co-authored papers 2
Co-authored papers 2
Rollins School of Public Health, Emory University
Co-authored papers 2
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2